Literature DB >> 17889931

Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey.

Samuel J Arbes1, Peter J Gergen, Ben Vaughn, Darryl C Zeldin.   

Abstract

BACKGROUND: The percentage of asthma cases attributable to atopy is the subject of debate.
OBJECTIVES: The objectives were to estimate the percentage of asthma cases in the US population attributable to atopy and to examine associations between allergen-specific skin tests and asthma.
METHODS: Data were obtained from the Third National Health and Nutrition Examination Survey, in which subjects age 6 to 59 years were skin tested with 10 allergens. Atopy was defined as at least 1 positive allergen-specific test. Doctor-diagnosed current asthma was assessed by questionnaire.
RESULTS: In the United States, 56.3% of the asthma cases were attributable to atopy, and that percentage was greater among males than females, among persons in the highest education category than in lower education categories, and among persons living in highly populated metropolitan areas than in all other areas. Each allergen-specific test was strongly associated with asthma before adjustment (odds ratios varied from 2.1 to 4.5); however, after adjustment by all the allergens, only tests to cat, Alternaria, white oak, and perennial rye were independently associated with asthma. Perennial rye was inversely associated with asthma. Of the 10 allergens, a positive response to cat accounted for the highest percentage of asthma cases (29.3%).
CONCLUSION: About half of the current asthma cases in the US population represented by the Third National Health and Nutrition Examination Survey were attributable to atopy. Some allergen-specific skin tests were not independently associated with asthma. CLINICAL IMPLICATIONS: If atopy could be prevented or reversed, or its effect on asthma blocked, then a large percentage of asthma cases in the US population could be prevented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889931      PMCID: PMC2291202          DOI: 10.1016/j.jaci.2007.07.056

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

1.  Proportion of disease caused or prevented by a given exposure, trait or intervention.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1974-05       Impact factor: 4.897

2.  Association of asthma with serum IgE levels and skin-test reactivity to allergens.

Authors:  B Burrows; F D Martinez; M Halonen; R A Barbee; M G Cline
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group.

Authors:  S Lau; S Illi; C Sommerfeld; B Niggemann; R Bergmann; E von Mutius; U Wahn
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

4.  Which clinical subgroups within the spectrum of child asthma are attributable to atopy?

Authors:  Anne-Louise Ponsonby; Paul Gatenby; Nicholas Glasgow; Raymond Mullins; Tim McDonald; Mark Hurwitz
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

5.  Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study.

Authors:  T Platts-Mills; J Vaughan; S Squillace; J Woodfolk; R Sporik
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

6.  Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study.

Authors:  S H Arshad; S M Tariq; S Matthews; E Hakim
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Contribution of residential exposures to asthma in us children and adolescents.

Authors:  B P Lanphear; R S Kahn; O Berger; P Auinger; S M Bortnick; R W Nahhas
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

8.  Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: results from the National Survey of Lead and Allergens in Housing.

Authors:  Samuel J Arbes; Richard D Cohn; Ming Yin; Michael L Muilenberg; Warren Friedman; Darryl C Zeldin
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

9.  Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study.

Authors:  R Sporik; S T Holgate; T A Platts-Mills; J J Cogswell
Journal:  N Engl J Med       Date:  1990-08-23       Impact factor: 91.245

10.  National prevalence and exposure risk for cockroach allergen in U.S. households.

Authors:  Richard D Cohn; Samuel J Arbes; Renee Jaramillo; Laura H Reid; Darryl C Zeldin
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

View more
  56 in total

Review 1.  Drug development for severe asthma: what are the metrics?

Authors:  Cynthia B Robinson; Joanne Leonard; Reynold A Panettieri
Journal:  Pharmacol Ther       Date:  2012-05-22       Impact factor: 12.310

Review 2.  Early identification of atopy in the prediction of persistent asthma in children.

Authors:  Peter D Sly; Attilio L Boner; Bengt Björksten; Andy Bush; Adnan Custovic; Philippe A Eigenmann; James E Gern; Jorrit Gerritsen; Eckard Hamelmann; Peter J Helms; Robert F Lemanske; Fernando Martinez; Soren Pedersen; Harald Renz; Hugh Sampson; Erika von Mutius; Ulrich Wahn; Patrick G Holt
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

3.  Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization.

Authors:  Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

4.  Exposures to molds in school classrooms of children with asthma.

Authors:  Sachin N Baxi; Michael L Muilenberg; Christine A Rogers; William J Sheehan; Jonathan Gaffin; Perdita Permaul; Lianne S Kopel; Peggy S Lai; Jeffrey P Lane; Ann Bailey; Carter R Petty; Chunxia Fu; Diane R Gold; Wanda Phipatanakul
Journal:  Pediatr Allergy Immunol       Date:  2013-11       Impact factor: 6.377

5.  Nitrogen dioxide and allergic sensitization in the 2005-2006 National Health and Nutrition Examination Survey.

Authors:  Charles H Weir; Karin B Yeatts; Jeremy A Sarnat; William Vizuete; Päivi M Salo; Renee Jaramillo; Richard D Cohn; Haitao Chu; Darryl C Zeldin; Stephanie J London
Journal:  Respir Med       Date:  2013-08-28       Impact factor: 3.415

6.  Racial disparities in allergic outcomes in African Americans emerge as early as age 2 years.

Authors:  G Wegienka; S Havstad; C L M Joseph; E Zoratti; D Ownby; K Woodcroft; C C Johnson
Journal:  Clin Exp Allergy       Date:  2012-06       Impact factor: 5.018

7.  Food allergy is associated with an increased risk of asthma.

Authors:  A Schroeder; R Kumar; J A Pongracic; C L Sullivan; D M Caruso; J Costello; K E Meyer; Y Vucic; R Gupta; J S Kim; R Fuleihan; X Wang
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

Review 8.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

9.  Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study.

Authors:  Amy M Linabery; Anna E Prizment; Kristin E Anderson; James R Cerhan; Jenny N Poynter; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

Review 10.  The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.

Authors:  Samuel Louie; Amir A Zeki; Michael Schivo; Andrew L Chan; Ken Y Yoneda; Mark Avdalovic; Brian M Morrissey; Timothy E Albertson
Journal:  Expert Rev Clin Pharmacol       Date:  2013-03       Impact factor: 5.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.